Yet, Brand et al. showed that some HPV(+) HNSCC cell models, and patient-derived xenografts (PDXs) could be resistant to the PI3K pathway inhibitor, BYL-719 [73]. This evidence concerns the gene PIK3CG and head and neck squamous cell carcinoma.